These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23500243)
1. Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure. Samara MA; Tang WH; Cikach F; Gul Z; Tranchito L; Paschke KM; Viterna J; Wu Y; Laskowski D; Dweik RA J Am Coll Cardiol; 2013 Apr; 61(13):1463-4. PubMed ID: 23500243 [No Abstract] [Full Text] [Related]
2. A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity. Yokokawa T; Sugano Y; Shimouchi A; Shibata A; Nakayama T; Ohara T; Jinno N; Kanzaki H; Anzai T Int J Cardiol; 2016 Feb; 204():112-3. PubMed ID: 26655553 [No Abstract] [Full Text] [Related]
3. Exhaled acetone as a new biomaker of heart failure severity. Marcondes-Braga FG; Gutz IGR; Batista GL; Saldiva PHN; Ayub-Ferreira SM; Issa VS; Mangini S; Bocchi EA; Bacal F Chest; 2012 Aug; 142(2):457-466. PubMed ID: 22345382 [TBL] [Abstract][Full Text] [Related]
4. Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry. Bikov A; Paschalaki K; Logan-Sinclair R; Horváth I; Kharitonov SA; Barnes PJ; Usmani OS; Paredi P BMC Pulm Med; 2013 Jul; 13():43. PubMed ID: 23837867 [TBL] [Abstract][Full Text] [Related]
5. Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure. Yokokawa T; Sato T; Suzuki S; Oikawa M; Yoshihisa A; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Shimouchi A; Takeishi Y Int Heart J; 2018 Jul; 59(4):808-812. PubMed ID: 29794390 [TBL] [Abstract][Full Text] [Related]
6. Change of Exhaled Acetone Concentration in a Diabetic Patient with Acute Decompensated Heart Failure. Yokokawa T; Ichijo Y; Houtsuki Y; Matsumoto Y; Oikawa M; Yoshihisa A; Sugimoto K; Nakazato K; Suzuki H; Saitoh SI; Shimouchi A; Takeishi Y Int Heart J; 2017 Oct; 58(5):828-830. PubMed ID: 28966328 [TBL] [Abstract][Full Text] [Related]
7. Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up. Marcondes-Braga FG; Batista GL; Gutz IG; Saldiva PH; Mangini S; Issa VS; Ayub-Ferreira SM; Bocchi EA; Pereira AC; Bacal F PLoS One; 2016; 11(12):e0168790. PubMed ID: 28030609 [TBL] [Abstract][Full Text] [Related]
8. Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry. Biagini D; Lomonaco T; Ghimenti S; Bellagambi FG; Onor M; Scali MC; Barletta V; Marzilli M; Salvo P; Trivella MG; Fuoco R; Di Francesco F J Breath Res; 2017 Nov; 11(4):047110. PubMed ID: 29052557 [TBL] [Abstract][Full Text] [Related]
9. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children. Alkhouri N; Cikach F; Eng K; Moses J; Patel N; Yan C; Hanouneh I; Grove D; Lopez R; Dweik R Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):82-7. PubMed ID: 24284369 [TBL] [Abstract][Full Text] [Related]
10. Alveolar air volatile organic compound extractor for clinical breath sampling. de Silva G; Beyette FR Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5369-72. PubMed ID: 25571207 [TBL] [Abstract][Full Text] [Related]
11. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath. Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239 [TBL] [Abstract][Full Text] [Related]
19. Sensors for Enhanced Detection of Acetone as a Potential Tool for Noninvasive Diabetes Monitoring. Rydosz A Sensors (Basel); 2018 Jul; 18(7):. PubMed ID: 30012960 [TBL] [Abstract][Full Text] [Related]